NCT05086393View on ClinicalTrials.gov

Duloxetine RCT on Postop TKA Outcomes

PHASE4RecruitingINTERVENTIONAL
Enrollment

504

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

June 1, 2025

Study Completion Date

November 15, 2025

Conditions
Pain, PostoperativeTotal Knee Arthroplasty
Interventions
DRUG

Duloxetine

Patients will be randomized to receive Duloxetine or a placebo.

DRUG

Placebos

Patients will be randomized to receive Duloxetine or a placebo.

Trial Locations (1)

60612

RECRUITING

Rush University medical Center, Chicago

All Listed Sponsors
lead

Rush University Medical Center

OTHER